SCHEMBL7769423

SCHEMBL7769423

CSc1nc(C)c(-c2ccccc2)[nH]1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.69
HPGD P15428 2/20 0.69
ALDH1A1 P00352 2/20 0.69
LMNA P02545 1/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
PTGS1 P23219 1/20 0.52
PTGS2 P35354 1/20 0.52
XDH P47989 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PPARG P37231 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
NCOR2 Q9Y618 1/20 0.44
DCUN1D1 Q96GG9 1/20 0.43
MAPK13 O15264 2/20 0.42
MAPK12 P53778 2/20 0.42
MAPK11 Q15759 2/20 0.42
MAPK14 Q16539 2/20 0.42
NPSR1 Q6W5P4 1/20 0.41
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3382433 0.81 KDM4E (1.00) KDM4EHPGDALDH1A1LMNAL3MBTL1
SCHEMBL11516210 0.79 MAPK13 (0.53) KDM4EHPGDALDH1A1LMNAL3MBTL1
SCHEMBL5850257 0.76 KDM4E (0.68) KDM4EHPGDALDH1A1LMNAL3MBTL1
SCHEMBL1980159 0.73 XDH (0.50) KDM4EHPGDALDH1A1LMNAL3MBTL1
SCHEMBL7769428 0.73 KDM4E (0.48) KDM4EHPGDALDH1A1LMNAL3MBTL1
SCHEMBL16868394 0.73 KDM4E (0.48) KDM4EHPGDALDH1A1LMNAL3MBTL1
SCHEMBL23758282 0.73 GAA (0.58) KDM4EHPGDALDH1A1SMN1; SMN2MAPK13
SCHEMBL8313104 0.73 MEN1 (0.47) KDM4EHPGDALDH1A1LMNAL3MBTL1
SCHEMBL4111920 0.70 KDM4E (0.69) KDM4EHPGDALDH1A1LMNAL3MBTL1
SCHEMBL19116734 0.70 L3MBTL1 (0.61) KDM4EHPGDALDH1A1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1112072-A2 METHIMAZOLE DERIVATIVES AND TAUTOMERIC CYCLIC THIONES TO TREAT AUTOIMMUNE DISEASES Sentron Medical, Inc. (US) 2001-07-04 EP disclosed
WO-2000012175-A2 METHIMAZOLE DERIVATIVES AND TAUTOMERIC CYCLIC THIONES TO TREAT AUTOIMMUNE DISEASES SENTRON MEDICAL, INC. (US) 2000-03-09 WO disclosed